Related Experiment Video
Updated: May 4, 2026

Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
The case for involvement of spiroplasma in the pathogenesis of transmissible spongiform encephalopathies
1From the Department of Animal Science, Louisiana State University Agricultural Center, Baton Rouge, Louisiana.
Abstract:
Spiroplasma biofilm formation explains the role of these wall-less bacteria in the pathogenesis of transmissible spongiform encephalopathies (TSEs). Spiroplasma embedded in the biofilm polysaccharide matrix are markedly resistant to physical and chemical treatment, simulating the biologic properties of the TSE agent. Microcolonies of spiroplasma embedded in biofilm bound to clay are the likely mechanism of lateral transmission of scrapie in sheep and chronic wasting disease in deer via soil ingestion. Spiroplasma in biofilm bound to the stainless steel of surgical instruments may also cause iatrogenic transmission of Creutzfeldt-Jakob disease. Sessile spiroplasma in biofilm attach to the surface by curli-like fibrils, a functional amyloid that is important for spiroplasma entering cells. Curli fibers have been shown to interact with host proteins and initiate formation of a potentially toxic amyloid that multiplies by self-assembly. In TSE, this mechanism may explain how spiroplasma trigger the formation of prion amyloid. This possibility is supported by experiments that show spiroplasma produce α-synuclein in mammalian tissue cultures. The data linking spiroplasma to neurodegenerative diseases provide a rationale for developing diagnostic tests for TSE based on the presence of spiroplasma-specific proteins or nucleic acid. Research efforts should focus on this bacterium for development of therapeutic regimens for Creutzfeldt-Jakob disease.
Insights
Spiroplasma bacteria form biofilms, potentially explaining their role in transmissible spongiform encephalopathies (TSEs). This biofilm formation may explain prion amyloid development and disease transmission, suggesting new diagnostic and therapeutic targets for neurodegenerative diseases.
Area of Science:
- Microbiology
- Neuroscience
- Infectious Diseases
Background:
- Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
- The exact cause and transmission mechanisms of TSEs remain incompletely understood.
- Spiroplasma, a genus of wall-less bacteria, has been implicated in TSE pathogenesis.
Purpose of the Study:
- To investigate the role of Spiroplasma biofilm formation in TSE pathogenesis.
- To explore Spiroplasma's potential contribution to prion amyloid formation.
- To identify Spiroplasma as a potential target for TSE diagnostics and therapeutics.
Main Methods:
- Analysis of Spiroplasma biofilm structure and resistance properties.
- Investigation of Spiroplasma's interaction with host proteins and amyloid formation.
- Examination of Spiroplasma's role in the transmission of scrapie and chronic wasting disease.
- Assessment of Spiroplasma's production of α-synuclein in mammalian cell cultures.
Main Results:
- Spiroplasma biofilms exhibit resistance to physical and chemical treatments, mimicking TSE agent properties.
- Spiroplasma biofilms bound to clay particles may facilitate the lateral transmission of scrapie and chronic wasting disease.
- Spiroplasma biofilms on surgical instruments could contribute to iatrogenic transmission of Creutzfeldt-Jakob disease.
- Spiroplasma's curli-like fibrils may initiate host prion amyloid formation, potentially through α-synuclein production.
Conclusions:
- Spiroplasma biofilm formation is a plausible mechanism explaining the pathogenesis and transmission of TSEs.
- Spiroplasma's ability to trigger prion amyloid formation warrants further investigation.
- Developing diagnostic tests and therapeutic strategies targeting Spiroplasma is crucial for managing TSEs, including Creutzfeldt-Jakob disease.
Related Concept Videos
Bacterial Phylum Spirochaetes
Bacterial Phylum Tenericutes
Bacterial Meningitis II: Pathophysiology
Fungal Phylum Microsporidia
Subviral Agents
Encephalitis ll: Pathophysiology

